диссертации / 130

232.McLenachan, J.M. Early evidence of endothelial vasodilator dysfunction at coronary branch points / J.M. McLenachan, J. Vita, D.R. Fish, C.B. Treasure, D.A. Cox, P. Ganz, A.P. Selwyn // Circulation. - 1990. - Vol. 82(21). - P. 1169-1173.

233.Meilin, S. Treatment with Actovegin improves spatial learning and memory in rats following transient forebrain ischaemia / S. Meilin, F. Machicao, M. Elmlinger // J. Cell. Mol. Med. - 2014. - Vol.18(8). - P. 1623-1630.

234.Molnár, P. Vinpocetine is as potent as phenytoin to block voltage-

gated Na+ channels in rat cortical neurons / P. Molnár, S.L. Erdö // Eur. J.

Pharmacol. - 1995. Vol. 273(5). - P. 303-306.

235.Moncada, S. XIV International Union of Pharmacology Nomenclature in Nitric Oxide Research / S. Moncada, A. Higgs, R. Furchgott // Pharmacol. Reviews. – 1997. - Vol.49(2). – P. 137-142.

236.Mudau, M. Endothelial dysfunction: the early predictor of atherosclerosis / M. Mudau, A. Genis, A. Lochner, H. Strijdom // Cardiovasc. J. Afr. - 2012. - Vol. 23(4). P. 222-231.

237.Muiesan, M.L. Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension / M.L. Muiesan, M. Salvetti, C. Monteduro, D. Rizzoni, R. Zulli, C. Corbellini, C. Brun, E. Agabiti-Rosei // Hypertension. - 1999. - Vol. 33 (1 Pt 2). - P. 575-580.

238.Murphy, M.P. Nitric oxide and cell death / M.P. Murphy // Biochim. Biophys.Acta. - 1999. - Vol. 1411. - P. 401-414.

239.Naka, K.K. Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function / K.K. Naka, A.C. Tweddel, S.N. Doshi, J. Goodfellow, A.H. Henderson // Eur. Heart J. - 2006. - Vol. 27(3). - P. 302-309.

240.Nakayama, N. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro / N. Nakayama, K. Ikezono, M. Ohura, Y. Yabuuchi // Arzneimittelforschung. - 1993. - Vol. 43(12). - P. 1266-1270.

171

241.Narahashi, T. Chemical modulation of sodium channels and GABAA receptor channel / T. Narahashi // Adv.Nevrol. - 1999. - V.96(79). - P. 457-480.

242.Narshi, C.B. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus? / C.B. Narshi, I.P. Giles, A. Rahman // Lupus. - 2011. - Vol. 20. - P. 5 - 13.

243.Naruse, K. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation / K. Naruse, K. Shimizu, M. Muramatsu, Y. Toki, Y. Miyazaki, K. Okumura, H. Hashimoto, T. Ito // Arterioscler. Thromb. - 1994. - Vol. 14(5). - P. 746-752.

244.Neven, E. Cell biological and physicochemical aspects of arterial calcification / E. Neven, T.M. De Schutter, M.E. De Broe, P.C. D'Haese // Kidney Int. - 2011. - Vol. 79(11). - P. 1166-1177.

245.Newaz, M.A. Аlpha-Tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats / M.A. Newaz, N.N. Nawal, C.H. Rohaizan, N. Muslim, A. Gapor // Am. J. Hypertens. - 1999. - Vol. 12 (8 Pt 1). - P. 839-844.

246.Novosel, D. Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone rat: effects of therapy with verapamil and trandolapril alone and in combination / D. Novosel, M.G. Lang, G. Noll, T.F. Luscher // J. Cardiovasc. Pharmacol. - 1994. - Vol.24 (6). - P. 979-985.

247.O'Leary, D.H. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group / D.H. O'Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke et al. // N. Engl. J. Med. — 1999. Vol. 340. - P. 14-22.

248.Omland, T. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction / T. Omland, R.T. Lie, A. Aakvaag, T. Aarsland, K. Dickstein // Circulation. – 1994. – Vol.89. – P. 15731579.

172

249.Ono, Y. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats / Y. Ono, H. Ono, E.D. Frohlich // J. Hypertens. - 1996. - Vol. 14 (7). - P. 823-828.

250.Panigrahi, M. Alpha lipoic acid protects against reperfusion injury following cerebral ischemia in rats / M. Panigrahi, Y. Sadguna, B.R. Shivacumar, V.R.K. Sastry, S. Roy, L. Packer // Brain Res. - 1996. - Vol. 717. - P. 184-188.

251.Panza, J.A. Endothelial dysfunction in essential hypertension / J.A. Panza // Clin. Cardiol. - 1997. - Vol. 20 (11 Suppl. 2). - P. 26-33.

252.Panza, J.A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension / J.A. Panza, P.R. Casino, C.M. Kilcoyne, A.A. Quyyumi // Circulation. - 1993. - Vol. 87(5). P. 1468-1474.

253.Parenti, A. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol / A. Parenti, S. Filippi, S. Amerini, H.J. Granger, A. Fazzini, F. Ledda // J. Pharmacol. Exp. Ther. - 2000. - Vol. 292(2). - P. 698-703.

254.Pepine, C.J. Vascular health as a therapeutic target in cardiovascular disease / C.J. Pepine, D.S. Celermajer, H. Drexler. - University of Florida, 1998. - 120 pp.

255.Perticone, F. Prognostic significance of endothelial dysfunction in hypertensive patients / F. Perticone, R. Ceravolo, A. Pujia // Circulation. – 2001. –

Vol.104. – P. 191-196.

256.Pinsky, M.R. Cerebral Blood Flow. Mechanisms of ischemia, diagnosis, and therapy / M.R. Pinsky. - Berlin: Springer, 2002. - 312 p.

257.Richard, V. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects / V. Richard, R. Joannides, J.P. Henry, P. Mulder, B. Mace, D. Guez, P. Schiavi, C. Thuillez // J. Hypertens. - 1996. - Vol. 14(12). - P. 1447-1454.

173

258. Ridker, P.M. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men / P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, J. Allen // Lancet. – 1998. – Vol.351. – P. 88-92.

259.Rischke, R. Effects of vinpocetine on local cerebral blood flow and glucose utilization seven days after forebrain ischemia in the rat / R. Rischke, J. Krieglstein // Pharmacology. - 1990. - Vol. 41(3). - P. 153-160.

260.Ritz, E. Nephropathy in patients with type 2 diabetes melitus / E. Ritz, S.R. Orth // N.Engl.J.Med. - 1999. - №341. - P. 1127-1133.

261.Rosenson, R.S. Distribution of blood viscosity values and biochemical correlates in healthy adults / R.S. Rosenson, A. McCormick, E.F. Uretz // Clin. Chem. - 1996. - Vol. 42(8 P 1). - P. 1189-1195.

262.Ross, R. The pathogenesis of atherosclerosis: part 1 / R. Ross , J. Glomset // N. Engl. J. Med. - 1976. - Vol. 295. - P. 369–377, 420–428.

263.Rössig, L. Apoptosis in the vascular wall and atherosclerosis / L.

Rössig, S. Dimmeler, A.M. Zeiher // Basic Res. Cardiol. - 2001. - Vol. 96(1). - P.

11-22.

264.Sabharwal, A.K. Alpha-Lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells / A.K. Sabharwal, J.M. May // Mol. Cell. Biochem. - 2008.- 309(1-2). - P. 125-132.

265.Safar, M.E. The common carotid circulation in patients with essential hypertension / M.E. Safar, S. Laurent, A. Benetos, G.M. London // Strok. - 1988. - Vol.19. - P. 1198-1202.

266.Saxena, R. Postprandial hypertriglyceridemia and oxidative stress in patients of type 2 diabetes melluitus with macro vascular complications / R. Saxena, S.V. Madhu, R. Shukla, K.M. Prabhu, J.K. Gambhir // Clinical Chimica. Acta. - 2005. - Vol.359. - P. 101-108.

174

267.Schachinger, V. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease / V. Schachinger, M.B. Britten, A.M. Zeiher // Circulation. – 2000. – Vol.101. – P. 1899-1906.

268.Schini, V.B. Effects of indapamide on endothelium-dependent relaxations in isolated canine femoral arteries / V.B. Schini, J. Dewey, P.M. Vanhoutte // Am. J. Cardiol. - 1990. - Vol. 65(17). - P. 6H-10H.

269.Shah, P.K. New insights into the pathogenesis and prevention of acute coronary syndromes / P.K. Shah // Amer. J. Cardiol. - 1997. - Vol. 79 (12B). - P. 17-23.

270.Shechter, M. Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease / M. Shechter, A. Shechter, N. Koren-Morag, M.S. Feinberg, L. Hiersch // Am. J. Cardiol. - 2014. - Vol. 113(1). - P. 162-167.

271.Siegel, G. Endothelial dysfunction in human atherosclerotic coronary

arteries / G. Siegel, K. Rückborn, F. Schnalke, J. Müller // Eur. Heart. J. 1993. -

Vol. 14 (suppl 1). - P. 99-103.

272.Sola, S. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study / S. Sola, M.Q. Mir, F.A. Cheema, N. Khan-Merchant, R.G. Menon, S. Parthasarathy, B.V. Khan // Circulation. - 2005. - Vol. 111(3). - P. 343-348.

273.Sorensen, K.E. Impairment of endothelium-dependent dilation is an early event in children with familiar hypercholesterolemia and is related to the lipoprotein (a) level / K.E. Sorensen, D.S. Celermajer, D. Georgakopoulos, G. Hatcher, D.J. Betteridge, J.E. Deanfield // J. Clin. Invest. – 1994. – Vol.93(1). – P. 50-55.

175

274.Sorensen, K.E. Atherosclerosis in the human brachial artery / K.E. Sorensen, I.B. Kristensen, D.S. Celermajer // J. Am. Coll. Cardiol. - 1997. - Vol. 29(2). - P. 318-322.

275.Stary, H.C. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association / H.C. Stary, A.B. Chandler, S. Glagov, J.R. Guyton, W.Jr. Insull, M.E. Rosenfeld, S.A. Schaffer, C.J. Schwartz, W.D. Wagner, R.W. Wissler // Arterioscler. Thromb. - 1994. - Vol.14(5). - P. 840-56.

276.Steinberg, H.O. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance / H.O. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel, A.D. Baron // J.Clin. Invest. – 1996. – Vol.97. – P. 2601-2610.

277.Stone, N.J. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines / N.J. Stone, J.G. Robinson, A.H. Lichtenstein et al. // Circulation. - 2014. - Vol. 24;129 (25 Suppl 2). - P. 1-45.

278.Sugawara, J. Effects of nitric oxide synthase inhibitor on decrease in peripheral arterial stiffness with acute low-intensity aerobic exercise / J. Sugawara, S. Maeda, T. Otsuki, T. Tanabe, R. Ajisaka, M. Matsuda // Am. J. Physiol. Heart. Circ. Physiol. - 2004. - Vol. 287(6).- P. 2666-2669.

279.Suwaidi, J.A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction / J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes, A. Lerman // Circulation. – 2000. –

Vol.101. – P. 948-954.

280. Taddei, S. Endothelial dysfunction in hypertension: fact or fancy? / S. Taddei, A. Virdis, L. Ghiadoni, A. Salvetti // J. Cardiovasc. Pharmacol. - 1998. - Vol. 3. P. 41-47.

176

281.Taddei, S. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension / S. Taddei, A. Virdis, L. Ghiadoni, I. Sudano, M. Notari, A. Salvetti // Circulation. - 1999. - Vol. 100 (16). - P. 1680-1683.

282.Taddei, S. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients / S. Taddei, A. Virdis, L. Ghiadoni, S. Uleri, A. Magagna, A. Salvetti // Hypertension. - 1997. - Vol. 30(6). - P. 1606-1612.

283.Taddei, S. Hypertension causes premature aging of endothelial function in humans / S. Taddei, A. Virdis, P. Mattei, L. Ghiadoni, C.B. Fasolo, I. Sudano, A. Salvetti // Hypertension. – 1997. – Vol.29. – P. 736-743.

284.Taddei, S. Vasodilation to acetylcholine in primary and secondary forms of human hypertension / S. Taddei, A. Virdis, P. Mattei, A. Salvetti // Hypertension. - 1993. - Vol. 21 (6 Pt 2). - P. 929-933.

285.Tak, W.W. Endothelial dysfunction: the common consequence in diabetes and hypertension / W.W. Tak et al. // J. Cardiovasc. Pharmacol. - 2010. - Vol. 55. - P. 300-307.

286.Takase, H. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril / H. Takase,

P. Moreau, C.F. Küng, E. Nava, T.F. Lüscher // Hypertension. - 1996. - Vol. 27(1). - P. 25-31.

287.Tanner, F.C. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived

nitric oxide / F.C. Tanner, G. Noll, C.M. Boulanger, T.F. Lüscher // Circulation. - 1991. - Vol. 83(6). -P. 2012-2020.

288. Targonski, P.V. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events / P.V. Targonski, P.O. Bonetti, G.M. Pumper, S.T. Higano, D.R. Jr. Holmes, A. Lerman // Circulation. – 2003. – Vol.107. – P. 2805-2809.

177

289.Tarry, W.C. L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty / W.C. Tarry, R.G. Makhoul // Arterioscler. Thromb. - 1994. - Vol. 14(6). -P. 938-943.

290.Thalhammer, C. Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbed carbohydrate metabolism in patients at risk for cardiovascular disease / C. Thalhammer, B. Balzuweit, A. Busjahn, С. Walter, F.C. Luft, H. Haller // Arteriosclerosis, thrombosis, and vascular biology. - 1999. - Vol. 19(5). - P. 1173-1179.

291.Tschudi, M.R. Antihypertensive therapy augments endotheliumdependent relaxations in coronary arteries of spontaneously hypertensive rats /

M.R. Tschudi, L. Criscione, D. Novosel, K. Pfeiffer, T.F. Lüscher // Circulation. -

1994. - Vol. 89(5). - P. 2212-2218.

292.Vallance, P.J. Vascular Endothelium in Human Physiology and Pathophysiology / P.J. Vallance, D.J. Webb. - CRC Press., 2000. - 302 p.

293.Vamosi, B. Comparative study of the effect of ethyl apovincaminate and xantinol nicoti-nate in cerebrovascular diseases / B. Vamosi, L. Molkarv, I. Demeter, F. Tury // Arzneimittel-Forschung. - 1976. - Vol. 26(23). - P. 1980-1984.

294.Vane, J.R. Regulatory functions of the vascular endothelium / J.R.

Vane, E.E. Anggård, R.M. Botting // N. Engl. J. Med. - 1990. - Vol.5;323(1). - P.

27-36.

295.Vaughan, D.E. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators / D.E. Vaughan, J.L. Rouleau, P.M. Ridker, J.M. Arnold, F.J. Menapace, M.A. Pfeffer // Circulation. - 1997. - V. 96(2). - P. 442-447.

296.Verma, S. Fundamentals of endothelial function for the clinical cardiologist / S. Verma, T.J. Anderson // Circulation.- 2002.- Vol.105.- P. 546-549.

297.Verma, S. Endothelial function testing as a biomarker of vascular disease / S. Verma, M.R. Buchanan, T.J. Anderson // Circulation. – 2003. - Vol.

108.– P. 2054-2059.

178

298.Versari, D. Endothelial dysfunction as a target for prevention of cardiovascular disease / D. Versari et al. // Diabetes Care. - 2009. - Vol. 32. - P. 314-321.

299.Vita, J.A. Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium / J.A. Vita, J. Loscalzo // Circulation.

-2002. – Vol.106. – P. 164-166.

300.Wang, X.Q. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells / X.Q. Wang, N.D. Vaziri // Hypertension. 1999. - Vol. 33(3). - P. 894-899.

301.Webb, D. Endothelial function in hypertension / D. Webb, P. Vallance. - Springer-Verlag Berlin Heidelberg, 1997. - 154 p.

302.Widlansky, M.E. The clinical implications of endothelial dysfunction / M.E. Widlansky, N. Gokce, J.F. Jr. Keaney, J.A. Vita // Journal of the American College of Cardiology. - 2003 - Vol. 42(7) - P. 1149–1160.

303.Wilkinson, I.B. Cholesterol, endothelial function and cardiovascular disease / I.B. Wilkinson, J.R. Cockcroft // Curr. Opin.Lipidol. - 1998. - Vol. 9(3). - P. 237-242.

304.Willis, A.L. Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits / A.L. Willis, B. Nagel, V. Churchill, M.A. Whyte, D.L. Smith, I. Mahmud, D.L. Puppione // Arteriosclerosis. - 1985. - Vol.5(3). - P. 250255.

305.Woodman, O.L. Modulation of vasoconstriction by endotheliumderived nitric oxide: the influence of vascular disease / O.L. Woodman // Clin. Exp. Pharmacol. Physiol. - 1995. - Vol. 22(9). - P. 585-593.

306.Wu, C.C. Nitric oxide synthase in spontaneously hypertensive rats / C.C. Wu, M.H. Yen // J. Biomed. Sci. - 1997. - Vol. 4(5). - P. 249-255.

307.Yamaoka, S. Relationship of serial measurements of cerebral hemodynamics to prognosis in patients with hypertension and cerebral disease / S.

179

Yamaoka, Y. Takagi, T. Okada, Y. Saito // Stroke. - 1972. - Vol.3. - №1. - P. 57-

66.

308.Yang, J. Pranidipine enhances the action of nitric oxide released from endothelial cells / J. Yang, K. Fukuo, S. Morimoto, T. Niinobu, T. Suhara, T. Ogihara // Hypertension. - 2000. - Vol. 35 (1 Pt 1). - P. 82-85.

309.Yang, Z. Recent advances in understanding endothelial dysfunction in atherosclerosis / Z. Yang, X.F. Ming // Clinical medicine and research. – 2006. –

Vol.4, №1. – P. 53-65.

310.Young, R.H. Cilazapril reverses endothelium-dependent vasodilator response to acetylcholine in mesenteric artery from spontaneously hypertensive rats / R.H. Young, Y.A. Ding, Y.M. Lee, M.H. Yen // Am. J. Hypertens. - 1995. - Vol. 8(9). - P. 928-933.

311.Zalba, G. Oxidative stress in arterial hypertension: role of NAD(P)H

oxidase / G. Zalba, G. San José, M.U. Moreno, M.A. Fortuño, A. Fortuño, F.J.

Beaumont, J. Díez // Hypertension. -2001. - Vol. 38(6). - P. 1395-1399.

312. Zhang, X. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent / X. Zhang, T.H. Hintze // Circulation. - 1998. - Vol. 97(6). - P. 576-580.

180